Skip to content

Clinical trials

Terminated Phase 2 Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Status: Terminated Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20083
20092
20101
20112
20122
20131
20142
20155
20172
20192
20203
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
M.D. Anderson Cancer Center2
Anchiano Therapeutics Israel Ltd.1
Andrew Ko1
Bristol-Myers Squibb1
Cedars-Sinai Medical Center1
Centre Oscar Lambret1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Elevation Oncology1
Fudan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma31
Carcinoma, Non-Small-Cell Lung7
Neoplasms6
Carcinoma5
Pancreatic Neoplasms5
Carcinoma, Squamous Cell4
Neoplasms, Glandular and Epithelial4
Stomach Neoplasms4
Neoplasms by Site3
Rectal Neoplasms3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.